The benefits of medical cannabis extend to many areas… and now threaten some very large campaign contributors, namely manufacturers of opioids, benzodiazepines and alcohol.
An early warning sign was the the 2014 survey by the National Pain Foundation that asked over 1,300 fibromyalgia patients to rate the effectiveness of the three FDA approved drugs. They also asked about medical marijuana.
The results were not encouraging for Big Pharma.
Although the FDA approved fibromyalgia drugs generate huge sales for Pfizer, Eli Lilly and Forest Laboratories, more than half the patients who tried their drugs found them totally worthless…. no help at all. In contrast, more than 50 percent of the patients who tried cannabis found it “very effective”.
Another 2014 study published in JAMA Internal Medicine found that opioid overdoses and deaths declined an average of 25 percent in states that had instituted medical cannabis programs. In addition, the longer medical cannabis was legal, the stronger the impact on reducing opioid overdose deaths. It was suggested that patients might be substituting cannabis for the opioid pain medication.